J. Meireles-Brandao/LinkedIn
Aug 3, 2026, 11:37
J. Meireles-Brandao: The Immunological Face of Atherosclerosis
J. Meireles-Brandao, Associate at SEDES – Association for Economic and Social Development, shared a post on LinkedIn:
“Immunology, Inflammation, Macrophages… LDLc, TC, TGRL, RC, MVR, ApoB, IL-6
- beyond Cholesterol and in the context of Lipoprotein Disease.
Reducing inflammatory markers is important, but it doesn’t immediately translate into fewer events.
Inflammation is a consequence, addressing the cause is crucial.”
Stay updated with Hemostasis Today.
-
Aug 3, 2026, 12:14Yaqui Valenzuela: Hemophilia Care Evolves Beyond Factor Replacement
-
Aug 3, 2026, 12:12José Antonio García Erce: Which Oral Iron Therapy Should We Choose?
-
Aug 3, 2026, 11:59Flora Peyvandi: Roctavian Withdrawal Signals Adoption Challenges
-
Aug 3, 2026, 11:49Thirunavukkarasu Angappan: Gene Therapy’s Slow Road to Routine Hemophilia Care
-
Aug 3, 2026, 11:48Francisco Chacón-Lozsán: From Protocols to Physiology in Septic Shock
-
Aug 3, 2026, 09:59Elizabeth Gardiner: Advancing Platelet Research Through Scientific Publishing at ISTH 2026
-
Aug 3, 2026, 09:25Sandeep De: Unraveling the Long-Term Impact of COVID-19 in Hemophilia
-
Aug 3, 2026, 08:57Nita Radhakrishnan: Moving Beyond Half-Life in Hemophilia Prophylaxis at NHU 2026
-
Aug 3, 2026, 08:47Neetu Gaur: Why Platelets Matter More Than You Think